$PRE

Alliance News says London stocks may open marginally higher as investors watch Strait of Hormuz talks and corporate earnings. Iran and Oman agreed a route and are finalizing joint management, but reopening depends on the US ending Iran port naval blockade. Company updates include WNX selling “Pain Away” to Mentholatum, Corero (CNS) revenue up 42% to $15.5m, PRE receiving $15m of a $165m investment, and TEK reporting H1 net assets $201.7m and profit after tax $144.8m.

PartnerRe reported first-half 2026 net income of $447 million, down from $493 million a year earlier, with operating income of $689 million and annualised operating ROE of 12.6%. Gross premiums written rose to $5.42 billion. Non-life underwriting profit was $396 million with a 85.1% combined ratio. Investment income increased to $491 million, but unrealised losses reduced net investment return.

Prenetics Global Limited (NASDAQ: PRE) said IM8 closed a $1 billion growth financing facility from General Catalyst’s Customer Value Fund to finance up to 70% of IM8 marketing spend. Prenetics raised 2026 IM8 revenue guidance to $210-220 million and expects $300 million annualized by year-end 2026 and $400 million+ in 2027. No equity was issued.

The article compiles 10 small-cap stocks (market caps $300M–$2B) chosen using analyst upside (≥20%) and hedge-fund ownership data (Q1 2026, Insider Monkey). It cites Tom Lee (Fundstrat) on chip/IPO-driven volatility and notes small caps’ YTD outperformance (Russell 2000 +18.6%). Reuters/EY data highlight biotech funding (+11% to $68.5B in 2025) and M&A ($84B Q1 2026).

CHARLOTTE, N.C., Nov. 25, 2025 ( GLOBE NEWSWIRE ) -- Prenetics Global Limited ( NASDAQ:PRE ) ( "Prenetics" or the "Company" ) , a leading health sciences company and parent of the IM8 premium health and longevity brand, today announced its participation in the following upcoming investor ...

CHARLOTTE, N.C., Nov. 25, 2025 ( GLOBE NEWSWIRE ) -- Prenetics Global Limited ( NASDAQ: PRE ) ( "Prenetics" or the "Company" ) , a leading health sciences company and parent of the IM8 premium health and longevity brand, today announced its participation in the following upcoming investor ...

CHARLOTTE, N.C., Nov. 24, 2025 ( GLOBE NEWSWIRE ) -- Prenetics Global Limited ( NASDAQ: PRE ) ( "Prenetics" or the "Company" ) , the parent company of IM8 and a global health-tech and longevity company pioneering a dual-engine strategy across consumer wellness and Bitcoin, today announced that ...

IM8's Strong Unit Economics-60% Margins and 3.9-Month Payback-Central to Cantor's Bullish Outlook ...

Prenetics Reports Record Third Quarter 2025 Results. IM8 on Track for $120M ARR by December 2025, Fastest Supplement Brand Growth in Industry History ...

Additional Bitcoin Acquisition Follows Immediately on $44 Million Equity Offering Company now holds a total of 378 BTC ( valued at ~$46 Million )